Evaxion Biotech A/S - American Depositary Share (EVAX)
1.8300
-0.0500 (-2.66%)
Evaxion Biotech A/S is a biotechnology company that focuses on the development of innovative immunotherapies and personalized cancer treatments using its proprietary artificial intelligence platform
The company specializes in designing and developing therapeutic vaccines that harness the body's immune system to target and destroy cancer cells. By leveraging advanced machine learning algorithms, Evaxion aims to identify optimal vaccine candidates tailored to individual patients, with the goal of providing more effective and customized treatment options for various types of cancer and infectious diseases.
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Evaxion Biotech enters an expanded collaboration with Merck, granting an option to license preclinical vaccine candidates. The deal includes $3.2 million upfront and potential earnings up to $592 million based on milestone achievements.
